Principal

Chief Financial Officer

Metabolomic Technologies Inc. is a privately held company developing metabolomics-based in vitro diagnostics for cancer and other diseases. Our lead product PolypDx™ is a urine-based screening test for the detection of adenomatous polyps and colorectal cancer.

Metabolomic Technologies Inc.

Junior Computing Scientist

Web Developer

Research Assistant

Volunteer

QA/RA Manager

Quality Assurance Manager

Director Of Quality

Associate Manager- Quality Assurance

Postdoctoral Fellow

ICP-MS Analyst

Master's

Business Development Associate

Senior Executive Vice President

Chairman of the Board

Founder

Investor

Senior Scientist

Analytical Method Development Lead

Postdoctoral Research Fellow

Laboratory Assistant

Administrative Assistant

Research Lab Manager

Research Associate

Mass Spectrometry Technologist

Metabolomics Technologist

Lab Analyst

Teaching Assistant

Partner & COO

Member, Board of Directors

Founder & CEO

President, MBA Student Association

Team Principal

Manufacturing Engineering

UAV Systems Engineering

Project Coordinator

Fleet Management

Mechanical Consultant

President & CEO

VP Finance, then President & CFO

Manager

VP, Corporate Development

Campaign Coordinator

Chief Operating Officer

Founder & Principal

Executive-in-Residence, Business Development

Executive-in-Residence, Business Development/Biotech

Director/Acting CEO

Director, Business Development

Manager of Business Development

General Manager, Commercial Business Unit

Manager of Operations

Operations Manager

President & Chief Operating Officer

DigitalOcean

Gmail

Google Apps

JW Player

YouTube

Google Font API

We are a Canadian publicly traded Canadian life-sciences company that provides innovation, proprietary drug delivery technologies designed to improve outcomes and quality of lives. RDT offers quick, convenient precise and discreet™ and smoke-free choices to consumers. RDT is focused on clinical research and product development for the healthcare manufacturing industry, including nutraceutical, pharmaceutical and cannabis industries. RDT is committed to innovative solutions for future market needs — including humans, animals and plants.We are now publicly listed on the Canadian Securities Exchange: $DOSE.

Rapid Dose Therapeutics (RDT)

Apache

Google Remarketing

reCAPTCHA

Shutterstock

Piwik

Twitter Advertising

Lithium Americas (TSX & NYSE: LAC) is focused on advancing Thacker Pass to production. Located in northern Nevada, Thacker Pass is the largest-known lithium M&I resource in the U.S. Construction commenced in early 2023 and is expected to create over 1,000 construction jobs and 500 permanent jobs during operations of its 40-year mine life. $LAC #lithium #Nevada

Ian Fodie

Chief Financial Officer at Metabolomic Technologies Inc.

Ian Fodie's Professional Contact Details

Ian Fodie's Current Company Details

Metabolomic Technologies Inc.

Ian Fodie's Work History and Education

Frequently Asked Questions about Ian Fodie

What company does Ian Fodie work for?

What is Ian Fodie's role at Metabolomic Technologies Inc.?

What is Ian Fodie's email address?

What is Ian Fodie's business email address?

What is Ian Fodie's direct mobile number?

What is Ian Fodie's HQ phone number?

What industry does Ian Fodie work in?

Who are Ian Fodie's colleagues?

Colleagues at Metabolomic Technologies Inc.

Prospect on LinkedIn

People Search

Company Search

Erik Straub

Michael Transon

Ready to try it out?